RAYMOND JAMES & ASSOCIATES - TRANSMEDICS GROUP INC ownership

TRANSMEDICS GROUP INC's ticker is TMDX and the CUSIP is 89377M109. A total of 180 filers reported holding TRANSMEDICS GROUP INC in Q3 2022. The put-call ratio across all filers is 0.85 and the average weighting 0.2%.

Quarter-by-quarter ownership
RAYMOND JAMES & ASSOCIATES ownership history of TRANSMEDICS GROUP INC
ValueSharesWeighting
Q3 2023$204,875
-58.1%
3,742
-35.7%
0.00%
Q2 2023$488,848
-68.2%
5,821
-71.3%
0.00%
-100.0%
Q1 2023$1,535,653
+246.3%
20,278
+182.3%
0.00%
Q4 2022$443,396
+94.5%
7,184
+31.2%
0.00%
Q3 2022$228,000
-36.1%
5,474
-36.3%
0.00%
Q1 2021$357,0008,5950.00%
Other shareholders
TRANSMEDICS GROUP INC shareholders Q3 2022
NameSharesValueWeighting ↓
KPCB XIII Associates, LLC 923,221$30,632,0005.64%
Sandhill Capital Partners LLC 1,429,432$47,429,0003.70%
Bullseye Asset Management LLC 117,471$3,898,0001.31%
Taylor Wealth Management Partners 72,685$2,412,0000.85%
Signature Wealth Management Partners, LLC 14,000$465,0000.42%
EMERALD MUTUAL FUND ADVISERS TRUST 369,259$12,252,0000.40%
Triumph Capital Management 20,051$622,0000.36%
EMERALD ADVISERS, LLC 300,464$9,969,0000.36%
ESSEX INVESTMENT MANAGEMENT CO LLC 76,347$2,533,0000.30%
Bellevue Group AG 729,989$24,221,0000.24%
View complete list of TRANSMEDICS GROUP INC shareholders